Literature DB >> 15576647

Fetal liver-sparing cardiovascular adaptations linked to mother's slimness and diet.

Guttorm Haugen1, Mark Hanson, Torvid Kiserud, Sarah Crozier, Hazel Inskip, Keith M Godfrey.   

Abstract

Fetal adaptations to impaired maternoplacental nutrient supply include altered regional blood flow. Whether such responses operate within the normal range of maternal body composition or diet is unknown, but any change in fetal liver perfusion could alter hepatic development, with long-term consequences for the risk of cardiovascular and metabolic disease. In 381 low-risk pregnancies, we found that the fetuses of slimmer mothers with lower body fat stores and those eating an unbalanced diet had greater liver blood flow and shunted less blood away from the liver through the ductus venosus at 36 weeks gestation. Consequences of such "liver-sparing" may underlie the increased cardiovascular risk of people whose mothers were slimmer and had lower body fat stores in pregnancy.

Entities:  

Mesh:

Year:  2004        PMID: 15576647     DOI: 10.1161/01.RES.0000152391.45273.A2

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  23 in total

Review 1.  The late effects of fetal growth patterns.

Authors:  F H Bloomfield; M H Oliver; J E Harding
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-07       Impact factor: 5.747

2.  The late gestation fetal cardiovascular response to hypoglycaemia is modified by prior peri-implantation undernutrition in sheep.

Authors:  Deborah M Burrage; Lucy Braddick; Jane K Cleal; Paula Costello; David E Noakes; Mark A Hanson; Lucy R Green
Journal:  J Physiol       Date:  2008-12-22       Impact factor: 5.182

Review 3.  Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms.

Authors:  Pathik D Wadhwa; Claudia Buss; Sonja Entringer; James M Swanson
Journal:  Semin Reprod Med       Date:  2009-08-26       Impact factor: 1.303

4.  Maternal malnutrition and placental insufficiency induce global downregulation of gene expression in fetal kidneys.

Authors:  O Denisenko; B Lin; S Louey; K Thornburg; K Bomsztyk; S Bagby
Journal:  J Dev Orig Health Dis       Date:  2011-04       Impact factor: 2.401

5.  Prospective association of fetal liver blood flow at 30 weeks gestation with newborn adiposity.

Authors:  Satoru Ikenoue; Feizal Waffarn; Masanao Ohashi; Kaeko Sumiyoshi; Chigusa Ikenoue; Claudia Buss; Daniel L Gillen; Hyagriv N Simhan; Sonja Entringer; Pathik D Wadhwa
Journal:  Am J Obstet Gynecol       Date:  2017-04-20       Impact factor: 8.661

6.  Gene expression profile differences in left and right liver lobes from mid-gestation fetal baboons: a cautionary tale.

Authors:  Laura A Cox; Natalia Schlabritz-Loutsevitch; Gene B Hubbard; Mark J Nijland; Thomas J McDonald; Peter W Nathanielsz
Journal:  J Physiol       Date:  2006-02-16       Impact factor: 5.182

7.  Cohort profile: The Southampton Women's Survey.

Authors:  Hazel M Inskip; Keith M Godfrey; Siân M Robinson; Catherine M Law; David J P Barker; Cyrus Cooper
Journal:  Int J Epidemiol       Date:  2005-09-29       Impact factor: 7.196

8.  Placental Corticotrophin-Releasing Hormone is a Modulator of Fetal Liver Blood Perfusion.

Authors:  Satoru Ikenoue; Feizal Waffarn; Masanao Ohashi; Mamoru Tanaka; Daniel L Gillen; Claudia Buss; Sonja Entringer; Pathik D Wadhwa
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

9.  Epigenetic modifications may play a role in the developmental consequences of early life events.

Authors:  Frank H Bloomfield
Journal:  J Neurodev Disord       Date:  2011-10-08       Impact factor: 4.025

10.  Fetal liver blood flow distribution: role in human developmental strategy to prioritize fat deposition versus brain development.

Authors:  Keith M Godfrey; Guttorm Haugen; Torvid Kiserud; Hazel M Inskip; Cyrus Cooper; Nicholas C W Harvey; Sarah R Crozier; Sian M Robinson; Lucy Davies; Mark A Hanson
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.